Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Verona的COPD药物商业化超预期的背后，折射出的是COPD适应症药物迭代的迫切需求，上一个时代的激素类药物和β受体激动剂都因为作用效果较为广谱而有众多副反应，针对PDE靶点的COPD药物已经初显峥嵘，之后还有TSLP靶点的单抗作为“预备队”，C ...

Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West ...

Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.

周三，HSBC维持对Cipla Ltd. (CIPLA:IN)的买入评级，但将目标价从此前的INR1,890.00下调至INR1,755.00。这一调整是在该公司公布2025财年第二季度业绩后做出的。HSBC保持积极态度，理由是公司在印度、南非和美国等关键市场的长期增长前景，以及谨慎的资本配置策略。 分析师认为，Cipla当前的股价已经反映了其果阿工厂最坏情况的预期。预计兰瑞肽销售的复苏以及新产品 ...

Seretide/Advair (fluticasone propionate + salmeterol; GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular ...

Shares of pharmaceutical giant Cipla dipped 5 per cent at Rs 1,403 per share on the NSE in Wednesday's intraday deals: Cipla ...

Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital ...

Dakota Wealth Management cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.8% in the 3rd quarter, ...